Jaguar Health, Inc. (JAGX) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Jaguar Health, Inc. (JAGX) Bundle
Enhance your investment strategies with the Jaguar Health, Inc. (JAGX) DCF Calculator! Explore authentic financial data, adjust growth projections and expenses, and instantly observe how these changes affect the intrinsic value of Jaguar Health, Inc. (JAGX).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.8 | 9.4 | 4.3 | 12.0 | 9.8 | 12.0 | 14.7 | 18.0 | 22.0 | 27.0 |
| Revenue Growth, % | 0 | 62.5 | -53.81 | 175.8 | -18.36 | 22.58 | 22.58 | 22.58 | 22.58 | 22.58 |
| EBITDA | -30.9 | -28.7 | -42.4 | -33.4 | -33.1 | -12.0 | -14.7 | -18.0 | -22.0 | -27.0 |
| EBITDA, % | -534.53 | -306.2 | -976.98 | -279.19 | -339.42 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.9 | 2.3 | 1.8 | 2.3 | 1.2 | 3.1 | 3.8 | 4.7 | 5.8 | 7.1 |
| Depreciation, % | 33.39 | 24.29 | 42.15 | 19.17 | 11.88 | 26.18 | 26.18 | 26.18 | 26.18 | 26.18 |
| EBIT | -32.8 | -31.0 | -44.2 | -35.7 | -34.3 | -12.0 | -14.7 | -18.0 | -22.0 | -27.0 |
| EBIT, % | -567.92 | -330.5 | -1019.12 | -298.36 | -351.31 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 3.5 | 8.1 | 17.1 | 5.5 | 6.5 | 8.6 | 10.5 | 12.9 | 15.8 | 19.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.7 | 4.6 | 2.1 | 2.5 | 2.0 | 4.0 | 4.9 | 6.0 | 7.4 | 9.1 |
| Account Receivables, % | 29.3 | 48.59 | 49.46 | 20.63 | 20.15 | 33.63 | 33.63 | 33.63 | 33.63 | 33.63 |
| Inventories | 2.1 | 2.8 | 4.9 | 7.0 | 9.2 | 7.6 | 9.4 | 11.5 | 14.1 | 17.3 |
| Inventories, % | 36.86 | 29.64 | 113.03 | 58.75 | 94.14 | 63.88 | 63.88 | 63.88 | 63.88 | 63.88 |
| Accounts Payable | 5.4 | 4.8 | 4.9 | 5.8 | 5.0 | 8.2 | 10.1 | 12.3 | 15.1 | 18.5 |
| Accounts Payable, % | 92.67 | 50.71 | 113.7 | 48.58 | 50.96 | 68.58 | 68.58 | 68.58 | 68.58 | 68.58 |
| Capital Expenditure | .0 | .0 | .0 | -1.7 | .0 | -.3 | -.4 | -.5 | -.6 | -.8 |
| Capital Expenditure, % | 0 | -0.07458711 | -0.13841 | -14.01 | 0 | -2.84 | -2.84 | -2.84 | -2.84 | -2.84 |
| Tax Rate, % | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 |
| EBITAT | -32.8 | -33.8 | -50.6 | -35.0 | -33.8 | -11.9 | -14.6 | -17.9 | -21.9 | -26.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.3 | -35.6 | -48.3 | -35.9 | -35.1 | -6.4 | -11.9 | -14.6 | -17.9 | -22.0 |
| WACC, % | 17.11 | 17.11 | 17.11 | 16.78 | 16.87 | 17 | 17 | 17 | 17 | 17 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -42.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -22 | |||||||||
| Terminal Value | -149 | |||||||||
| Present Terminal Value | -68 | |||||||||
| Enterprise Value | -111 | |||||||||
| Net Debt | 31 | |||||||||
| Equity Value | -142 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | -368.43 |
What You Will Get
- Real Jaguar Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Jaguar Health, Inc. (JAGX).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates to fit your analysis needs.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Jaguar Health's fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections specific to Jaguar Health, Inc. (JAGX).
- Time-Saving and Accurate: Avoid building models from the ground up while ensuring precision and adaptability.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Jaguar Health, Inc. (JAGX).
- WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Jaguar Health, Inc. (JAGX).
- Interactive Dashboard and Charts: Visual representations of key valuation metrics for streamlined analysis.
How It Works
- Download: Get the pre-built Excel file containing Jaguar Health, Inc.'s (JAGX) financial data.
- Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and instantly compare results.
- Make Decisions: Leverage the valuation insights to inform your investment strategy.
Why Choose This Calculator for Jaguar Health, Inc. (JAGX)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and industry consultants.
- Accurate Data: Jaguar Health’s historical and projected financials preloaded for precise analysis.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and accurate valuation models for investment analysis in the healthcare sector.
- Corporate Finance Teams: Evaluate financial scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Offer clients precise valuation insights for Jaguar Health, Inc. (JAGX) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling within healthcare.
- Health Tech Enthusiasts: Gain insights into how companies like Jaguar Health, Inc. (JAGX) are valued in the evolving healthcare market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Jaguar Health, Inc. (JAGX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Jaguar Health, Inc. (JAGX).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.